Skip to main content
SpringerLink
Log in

Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

A Viewpoint by Stephen T. Sonis

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

  1. Division of Oral Medicine, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, Boston, Massachusetts, USA

    Stephen T. Sonis

Authors
  1. Stephen T. Sonis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sonis, S.T. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis. Drugs 65, 2147–2149 (2005). https://doi.org/10.2165/00003495-200565150-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200565150-00012

Keywords

Search

Navigation